Lebwohl, M.; Sugarman, J.; Pariser, D.; Bagel, J.; Lin, T.; Israel, R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. J of Skin 2020, 4, S12.